JNJ Press releases
News
Other news
Nature Communications Article, Co-Authored by Paul Stoffels and William N. Hait Explores Importance of Academic-industrial Partnerships in Life Science Innovation
Read full storyJNJ Press releases
LAVA THERAPEUTICS PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER RESULTS
Read full storyJNJ Press releases
New report reveals strength of the UK’s thriving genomics sector
Read full storyJNJ Press releases
MESTAG THERAPEUTICS EXTENDS SEED FINANCING TO $45 MILLION AND WELCOMES NEW INVESTORS FORBION, GV (FORMERLY GOOGLE VENTURES) AND NORTHPOND VENTURES
Read full storyJNJ Press releases
Johnson & Johnson Innovation Announces Extension Of Innovation Partnering Office at Monash University In Collaboration With Victorian State Government To Accelerate The Life-Sciences Hub
Read full storyOther news
Ribon Therapeutics Secures $65 Million Financing
Read full storyOther news
Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)
Read full storyOther news
POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company
Read full storyOther news
TRexBio Closes the Final Tranche of $59 Million Series A Financing to Advance Innovation in Tissue Immunobiology for the treatment of Cancer and Inflammatory Diseases
Read full storyOther news
Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development
Read full storyOther news
Datavant and Ciox Health Announce Merger, Creating the Largest Neutral and Secure Health Data Ecosystem
Read full storyOther news
entrinsic bioscience Secures $49 million in Financing to Accelerate Development and Commercialization of Next Generation Functional Ingredients and Active Pharmaceutical Ingredients
Read full storyOther news
Thirty Madison Raises $140 Million in Series C Financing Led by HealthQuest Capital
Read full storyOther news